Author

Angelica M. Gutierrez‐Barrera

The University of Texas MD Anderson Cancer CenterORCID 0000-0002-8582-8186Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Assay:metabolomics· 1 Organism:mouse· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

Adriana A. Paulucci-HolthauzeniD· 1 shared Banu K AruniD· 1 shared Daniela Rodriguez-Perera· 1 shared Ehsan IrajizadiD· 1 shared Fu Chung Hsiao· 1 shared H. Krishna· 1 shared Hiroyuki KatayamaiD· 1 shared Jennifer B. DennisoniD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Adriana A. Paulucci-HolthauzenORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologyCell Reports MedicinePeer-reviewedDec 1, 2025

Vesicle-mediated mitochondrial clearance underlies an actionable metabolic vulnerability in triple-negative breast cancer

Jody Vykoukal, Yihui Chen, Mingxin Zuo…·Johannes Francois Fahrmann

The paper identifies a metabolic vulnerability in triple-negative breast cancer through sphingolipid metabolism, showing that targeting this pathway with eliglustat reduces tumor growth and improves survival.

6 citations

mouseproteomics

𝕏 PostBluesky